Skip to main content
logo
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
2.070
-0.070 (-3.27%)
At close: Aug 21, 2026, 4:00 PM EDT
2.066
-0.004 (-0.20%)
After-hours: Aug 21, 2026, 5:53 PM EDT

Polaryx Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
11.545.144.620
Cash & Short-Term Investments
11.545.144.620
Cash Growth
249.33%11.30%230950.00%-
Prepaid Expenses
0.27-0.382.31
Other Current Assets
-0.03--
Total Current Assets
11.815.1752.32
Total Assets
11.815.1752.32

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Accounts Payable
0.680.470.070.47
Accrued Expenses
0.190.140.220.44
Short-Term Debt
---0.13
Total Current Liabilities
0.870.610.291.04
Total Liabilities
0.870.610.291.04

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Common Stock
0.010.0100
Additional Paid-In Capital
114.49104.295.3661.57
Retained Earnings
-103.56-99.64-90.65-60.29
Shareholders' Equity
10.944.574.711.28
Total Liabilities & Equity
11.815.1752.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Total Debt
---0.13
Net Cash (Debt)
11.545.144.62-0.13
Net Cash Growth
249.33%11.30%--
Net Cash Per Share
0.250.110.14-0.01
Filing Date Shares Outstanding
49.8547.3441.1510.69
Total Common Shares Outstanding
49.8547.3441.1510.69
Working Capital
10.944.574.711.28
Book Value Per Share
0.220.100.110.12
Tangible Book Value
10.944.574.711.28
Tangible Book Value Per Share
0.220.100.110.12
SEC Filings: 10-K · 10-Q